Andrographis paniculata extract versus placebo in the treatment of COVID-19: a double-blinded randomized control trial

Andrographis paniculata extract versus placebo in the treatment of COVID-19: a double-blinded randomized control trial

Background and purpose: Andrographis paniculata (Burm.f.) Nees has been recommended to relieve symptoms and decrease the severity of COVID-19. The clinical study aimed to investigate the efficacy and safety of A. paniculata ethanolic extract (APE). Experimental approach: The efficacy and safety of A...

Full description

Bibliographic Details
Main Authors: Puritat Kanokkangsadal, Chatchai Mingmalairak, Nichamon Mukkasombat, Pranporn Kuropakornpong, Patsorn Worawattananutai, Thana Khawcharoenporn, Intouch Sakpakdeejaroen, Neal M Davies, Arunporn Itharat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
capsule; clinical trial; coronavirus; hplc.
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=6;spage=592;epage=603;aulast=Kanokkangsadal

Internet

http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=6;spage=592;epage=603;aulast=Kanokkangsadal

Similar Items